ACS Chemical Neuroscience
Scope & Guideline
Unraveling the Molecular Mysteries of Neural Function.
Introduction
Aims and Scopes
- Neurochemical Modulation and Drug Development:
A primary focus of the journal is the exploration of neurochemical pathways and the design of pharmacological agents aimed at modulating these pathways to treat neurological disorders such as Alzheimer's, Parkinson's, and depression. - Molecular Mechanisms of Neurodegeneration:
Research articles often delve into the molecular underpinnings of neurodegenerative diseases, investigating protein aggregation, oxidative stress, and neuroinflammation as key factors in disease progression. - Innovative Therapeutic Strategies:
The journal emphasizes the development of innovative strategies for neuroprotection and neuroregeneration, including the use of small molecules, peptides, and biologics to target specific pathways involved in neuronal health. - Advanced Imaging Techniques:
Articles frequently highlight advancements in imaging modalities, such as PET and MRI, which are crucial for understanding brain function and pathology at a molecular level. - Translational Research:
The journal promotes research that bridges the gap between laboratory discoveries and clinical applications, focusing on the therapeutic potential of new compounds and their mechanisms of action.
Trending and Emerging
- Neuroinflammation and Immune Modulation:
There is a marked increase in research investigating the role of neuroinflammation in various neurological disorders, along with approaches to modulate the immune response as a therapeutic strategy. - Psychedelic Compounds and Their Therapeutic Potential:
Recent papers have highlighted the exploration of psychedelics, such as psilocybin and LSD, for their potential therapeutic effects in treating mood disorders and other neuropsychiatric conditions, indicating a resurgence of interest in this area. - Artificial Intelligence and Machine Learning Applications:
The integration of AI and machine learning in drug discovery and neuroimaging is on the rise, reflecting a trend towards computational approaches that enhance the understanding of complex neurobiological systems. - Targeted Protein Degradation Technologies:
Research on targeted protein degradation, particularly in the context of neurodegenerative diseases, is gaining momentum as a novel therapeutic strategy to eliminate toxic protein aggregates. - Gut-Brain Axis Research:
There is an increasing focus on the gut-brain axis and its implications for neurodegenerative diseases and mental health, reflecting a broader understanding of the interconnectedness of physiological systems.
Declining or Waning
- Classical Neuropharmacology:
Research focusing solely on classical neuropharmacological agents, such as traditional antidepressants or anxiolytics, seems to be losing traction as the field shifts towards more complex, multimodal approaches to treatment. - Basic Neuroanatomy Studies:
Basic studies in neuroanatomy without a clear connection to functional implications or therapeutic applications are becoming less frequent, reflecting a shift towards more integrated and applied research. - Single Target Drug Development:
The trend towards developing single-target drugs appears to be waning, as there is a growing emphasis on multitarget approaches that address the multifaceted nature of neurological disorders. - In Vitro Models with Limited Relevance:
Research relying heavily on traditional in vitro models lacking translational relevance to human physiology is decreasing, as there is a greater demand for studies utilizing more sophisticated in vivo or organoid models.
Similar Journals
NEUROSCIENCE RESEARCH
Unveiling the Mysteries of the MindNEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.
Journal of Integrative Neuroscience
Advancing Neuroscience Through Interdisciplinary InnovationWelcome to the Journal of Integrative Neuroscience, a prominent platform dedicated to advancing the field of neuroscience by fostering interdisciplinary research and innovation. Published by IMR PRESS, this open-access journal has been committed to disseminating high-quality research since its inception in 2002, with a vision to integrate various aspects of neuroscience, from theoretical foundations to applied methodologies, ultimately enhancing our understanding of the brain and nervous system. With an evolving presence in the academic community, the journal holds significant rankings, such as Q2 in Medicine and Q3 in Neuroscience for 2023, reflecting its growing impact and value to researchers and professionals alike. The journal is accessible globally, having adopted an open-access model in 2018, ensuring that vital neuroscience findings reach a broader audience without barriers. Positioned in Singapore and serving an international readership, the Journal of Integrative Neuroscience is your essential resource for the latest insights and discoveries in a rapidly evolving field.
CELLULAR AND MOLECULAR NEUROBIOLOGY
Driving Progress in Cellular and Molecular Neuroscience.CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.
NEUROSCIENTIST
Exploring New Dimensions in Neuroscience ResearchNEUROSCIENTIST is a leading journal in the field of clinical neurology and neuroscience, published by SAGE Publications Inc. With an impressive impact factor reflected in its Q1 quartile ranking in both clinical neurology and miscellaneous neuroscience as of 2023, this journal positions itself as a crucial platform for the latest research and advancements in the neural sciences. Spanning from 1995 to 2024, NEUROSCIENTIST features a range of high-quality, peer-reviewed articles that cater to researchers, practitioners, and students alike. Although it does not offer Open Access options, the journal remains a vital resource owing to its Scopus rankings, situating it within the top percentile of its categories: ranked #28 out of 400 in clinical neurology and #15 out of 113 in general neuroscience. The journal's commitment to disseminating significant findings underlines its importance in fostering advancements in neurological understanding and treatment.
BMC NEUROSCIENCE
Exploring the Frontiers of Neuroscience ResearchBMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.
BRAIN RESEARCH
Exploring the intricate connections of neural systems.BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.
ASN Neuro
Unlocking the Mysteries of the Mind Through Open AccessASN Neuro is an esteemed academic journal published by Frontiers Media SA, focusing on critical advancements in the fields of neurology and neuroscience. Since its inception in 2009, it has established itself as an Open Access platform dedicated to fostering the dissemination of knowledge and research findings that address the complexities of the nervous system. With an impressive impact factor and consistently ranking in the top quartiles of its categories—Q1 in Neurology (clinical) and Q2 in Neuroscience (miscellaneous)—ASN Neuro is recognized for its high-quality publications that cater to the evolving challenges in clinical neurology and general neuroscience. Currently, it ranks 68th out of 400 journals in Clinical Neurology and 28th out of 113 in General Neuroscience, affirming its reputable position within the academic community. Researchers, professionals, and students alike are encouraged to contribute to and benefit from this impactful journal as it presents a unique opportunity to engage with cutting-edge research, innovative methodologies, and insightful reviews in the ever-evolving landscape of brain science.
eNeuro
Championing open access for transformative neurobiological insights.eNeuro is a prominent open-access journal published by the Society for Neuroscience, dedicated to advancing the field of neuroscience through the dissemination of high-quality research. Launched in 2015, it reflects its commitment to accessibility by providing a platform for innovative studies and advancements in neurobiology. The journal holds a strong reputation, achieving a Q1 ranking in Medicine (miscellaneous) and a Q2 in Neuroscience (miscellaneous) as of 2023, with Scopus rankings placing it at #56 out of 113 in General Neuroscience, marking it in the 50th percentile. With its convergence to cover articles from 2014 to 2024, eNeuro continues to serve as a vital resource for researchers, professionals, and students alike, offering a comprehensive hub for the latest discoveries and theoretical developments in neuroscience. As part of its mission, eNeuro aims to foster collaboration and inspire the academic community with openly accessible content, making significant contributions to scientific discourse.
Molecular Neurodegeneration
Advancing understanding of neurodegenerative diseases.Molecular Neurodegeneration is a leading journal published by BMC, dedicated to advancing the field of neurodegeneration through high-quality, open-access research. Since its inception in 2006, this peer-reviewed journal has provided a pivotal platform for the dissemination of innovative findings in the realms of Cellular and Molecular Neuroscience, Molecular Biology, and Clinical Neurology. With a stellar impact factor and listed in the prestigious Q1 category in multiple relevant categories, it ranks among the top publications in the field—specifically, it holds the #3 position in Neuroscience and #6 position in Clinical Neurology based on Scopus metrics. Researchers, professionals, and students alike will find significant value in the open access format, which fosters unrestricted sharing of knowledge, ensuring that emerging ideas in neurodegeneration reach a global audience. Based in London, United Kingdom, the journal promises a comprehensive scope that addresses critical questions in neurobiology, making it an essential resource for anyone interested in the molecular mechanisms underlying neurodegenerative diseases.
MOLECULAR NEUROBIOLOGY
Bridging Basic Science and Clinical InnovationWelcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.